Target type: molecularfunction
Binding to interleukin-8. [GOC:jl]
Interleukin-8 (IL-8), also known as CXCL8, is a chemokine primarily involved in the recruitment and activation of neutrophils, a type of white blood cell. It exerts its effects by binding to two specific G protein-coupled receptors (GPCRs) on the surface of target cells: CXCR1 and CXCR2. These receptors belong to the rhodopsin-like family of GPCRs, characterized by a seven-transmembrane domain structure. Upon binding to IL-8, these receptors activate intracellular signaling pathways, leading to a cascade of events culminating in neutrophil chemotaxis, activation, and degranulation. The binding of IL-8 to its receptors initiates a conformational change in the receptor, allowing the activation of heterotrimeric G proteins. These G proteins are composed of alpha, beta, and gamma subunits, and the alpha subunit is responsible for mediating downstream signaling events. Specifically, the activated alpha subunit dissociates from the beta and gamma subunits, and can then activate other intracellular signaling molecules, such as phospholipase C (PLC). PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol trisphosphate (IP3). DAG activates protein kinase C (PKC), while IP3 triggers the release of calcium ions from intracellular stores. The increase in intracellular calcium levels and the activation of PKC further contribute to the recruitment and activation of neutrophils. IL-8 binding also activates mitogen-activated protein kinases (MAPKs) and other signaling pathways, leading to the production of inflammatory mediators and the expression of adhesion molecules on the surface of neutrophils. These events facilitate the migration of neutrophils towards the site of inflammation and their interaction with the endothelium. Overall, IL-8 binding to its receptors on neutrophils plays a crucial role in the initiation and amplification of the inflammatory response by promoting neutrophil chemotaxis, activation, and degranulation, thus contributing to the defense against infections and tissue repair.'
"
Protein | Definition | Taxonomy |
---|---|---|
C-X-C chemokine receptor type 2 | A C-X-C chemokine receptor type 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P25025] | Homo sapiens (human) |
C-X-C chemokine receptor type 1 | A C-X-C chemokine receptor type 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P25024] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
clotrimazole | conazole antifungal drug; imidazole antifungal drug; imidazoles; monochlorobenzenes | antiinfective agent; environmental contaminant; xenobiotic | |
diclofenac | diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position. Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. | amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound | antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
disulfiram | organic disulfide; organosulfur acaricide | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor | |
itraconazole | piperazines | ||
dexibuprofen | dexibuprofen: structure in first source | ibuprofen | non-narcotic analgesic; non-steroidal anti-inflammatory drug |
ibuprofen, (r)-isomer | ibuprofen | ||
ketoprofen | |||
dexketoprofen | dexketoprofen : A monocarboxylic acid that is (S)-hydratropic acid substituted at position 3 on the phenyl ring by a benzoyl group. A cyclooxygenase inhibitor, it is used to relieve short-term pain, such as muscular pain, dental pain and dysmenorrhoea. | benzophenones; monocarboxylic acid | cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
sb 225002 | nitrophenol | ||
quercetin | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger | |
reparixin | reparixin: inhibits CXCR1 to prevent polymorphonuclear cell recruitment | monoterpenoid | |
sb 265610 | |||
sch 527123 | |||
sb 656933 | |||
amd 070 | mavorixafor: a derivative of AMD3100; a CXCR4 blocker | aminoquinoline | |
azd8309 | AZD8309: CXCR2 inhibitor | ||
a 803467 | A 803467: an Nav1.8 sodium channel blocker; structure in first source | ||
gsk1325756 | danirixin: structure in first source |